Search Results
Feb 16, 2026, 11:05 ET Hyundai IONIQ 5 N Named Best Performance EV by Car Talk
series of electrified 'Rolling Labs' (e.g., RM20e, RN22e and N Vision 74) vehicles. These allow Hyundai to maximize IONIQ 5 N's performance capabilities and ensure it meets N's three pillars of performance: Corner Rascal' Racetrack Capability, and Everyday Sportscar. Its electric motors provide up to
More news about: Hyundai Motor America
Feb 11, 2026, 18:01 ET IRBM, 지카 바이러스 치료제 개발에서 획기적 성과 보고
심각한 신경학적 합병증과의 연관성으로 인해 중대한 공중보건 위협으로 간주되고 있다. 현재 승인된 항바이러스제나 백신이 없는 상황에서, 새로운 치료 옵션에 대한 긴급한 수요가 지속되고 있다.IRBM 연구진은 바이러스 복제에 필수적인 핵심 효소인 NS2B-NS3 프로테아제의 기존에 규명되지 않았던 알로스테릭 부위에 결합하는 저분자 화합물을 확인했다. 해당 억제제는 생화학적•세포 기반 분석에서 프로테아제 활성을 효과적으로 억제했으며, 동물 모델에서도 유의미한 항바이러스 활성을 나타냈다. 또한 양호한 안전성과
More news about: IRBM S.p.A.
Feb 11, 2026, 09:11 ET IRBM 公布寨卡病毒藥物研發取得突破
經蚊子傳播的寨卡病毒 (ZIKV) 因與嚴重神經系統併發症相關，對公共衞生構成重大威脅。 目前尚無獲批的抗病毒藥物或疫苗，對全新的治療方案存在迫切需求。IRBM 科學家發現一種小分子，能與 NS2B-NS3 蛋白酶上一個此前尚未被表徵的變構位點結合，而該蛋白酶是病毒複製所需的關鍵酶。 該抑制劑在生化及細胞實驗中能有效抑制蛋白酶活性，並在 動物模型中展現顯著的抗病毒活性。 此外，它亦呈現良好的安全性及藥代動力學特性，支持其進一步進行臨床開發的潛力。
More news about: IRBM S.p.A.
Feb 10, 2026, 11:13 ET IRBM、ジカウイルス治療薬の発見において画期的な進展を報告
ローマ, 2026年2月10日 /PRNewswire/ -- 早期創薬研究のリーダーであるIRBMは、ジカウイルス（ZIKV）プロテアーゼ（NS2B-NS3）を標的とする強力なアロステリック阻害剤の新たな発見という、科学における画期的な進展を発表しました。Nature Communications（doi: 10.1038/s41467-026-68943-x）に掲載されたこの研究成果は、前臨床モデルにおける分子の有効性を実証しており、ZIKV感染症と闘うための有望な新しいアプローチとなります。
More news about: IRBM S.p.A.
Feb 10, 2026, 11:10 ET IRBM Relata Avanço na Descoberta de Medicamentos para o Zika Vírus
medicamentos, anunciou um grande avanço científico com a descoberta de um novo e potente inibidor alostérico direcionado à protease do vírus Zika (ZIKV) (NS2B-NS3). Os resultados, publicados na Nature Communications (doi: 10.1038/s41467-026-68943-x), demonstram a eficácia da molécula em modelos pré-clínicos
More news about: IRBM S.p.A.
Feb 10, 2026, 11:04 ET IRBM informa sobre un gran avance en el descubrimiento de fármacos contra el virus del Zika
un importante avance científico con el descubrimiento de un nuevo y potente inhibidor alostérico dirigido a la proteasa del virus del Zika (ZIKV) (NS2B-NS3). Los hallazgos, publicados en Nature Communications (doi: 10.1038/s41467-026-68943-x), demuestran la eficacia de la molécula en modelos preclínicos
More news about: IRBM S.p.A.
Feb 10, 2026, 09:25 ET IRBM informa sobre un avance en el descubrimiento de un fármaco contra el virus del Zika
fármacos, ha anunciado un importante avance científico con el descubrimiento de un novedoso y potente inhibidor alostérico dirigido a la proteasa (NS2B-NS3) del virus del Zika (ZIKV). Los hallazgos, publicados en Nature Communications (doi: 10.1038/s41467-026-68943-x), demuestran la eficacia de
More news about: IRBM S.p.A.
Feb 10, 2026, 09:13 ET L'IRBM fait état d'une avancée dans la découverte d'un médicament contre le virus Zika
de médicaments, a annoncé une percée scientifique majeure avec la découverte d'un nouvel et puissant inhibiteur allostérique ciblant la protéase (NS2B-NS3) du virus Zika (ZIKV). Les résultats, publiés dans Nature Communications (doi : 10.1038/s41467-026-68943-x), démontrent l'efficacité de la
More news about: IRBM S.p.A.
Feb 10, 2026, 07:10 ET IRBM meldet Durchbruch bei der Entdeckung von Medikamenten gegen das Zika-Virus
Behandlungsmöglichkeiten.Die IRBM-Wissenschaftler identifizierten ein kleines Molekül, das an eine bisher nicht charakterisierte allosterische Stelle der NS2B-NS3-Protease bindet, ein Schlüsselenzym, das für die virale Replikation erforderlich ist. Der Inhibitor unterdrückte die Proteaseaktivität in biochemischen
More news about: IRBM S.p.A.
Feb 10, 2026, 07:07 ET Long COVID Linked to Alzheimer's Disease Mechanisms
Debure, Mobeena Ghuman, Alok Vedvyas, and Arjun Masurkar.This research was supported by National Institute on Aging grants R01AG077422, U24 NS135568, and P30AG066512.About NYU Langone HealthNYU Langone Health is a fully integrated health system that consistently achieves the
More news about: NYU Grossman School of Medicine and NYU Langone Health
Feb 10, 2026, 06:00 ET IRBM Reports Breakthrough in Zika Virus Drug Discovery
for new treatment options.IRBM scientists identified a small molecule that binds to a previously uncharacterized allosteric site on the NS2B-NS3 protease, a key enzyme required for viral replication. The inhibitor effectively suppressed protease activity in biochemical and cellular assays
More news about: IRBM S.p.A.
Feb 10, 2026, 06:00 ET IRBM Reports Breakthrough in Zika Virus Drug Discovery
for new treatment options.IRBM scientists identified a small molecule that binds to a previously uncharacterized allosteric site on the NS2B-NS3 protease, a key enzyme required for viral replication. The inhibitor effectively suppressed protease activity in biochemical and cellular assays
More news about: IRBM S.p.A.
Feb 10, 2026, 06:00 ET Ricerca IRBM: un passo avanti verso nuove terapie contro il virus Zika
sviluppo preclinico di farmaci, annuncia un importante avanzamento scientifico con l'individuazione di un nuovo e potente inibitore della proteasi NS2B-NS3 del Virus Zika (ZIKV), un enzima essenziale per la replicazione virale. I risultati dello studio, pubblicati su Nature Communications (doi:
More news about: IRBM S.p.A.
Feb 06, 2026, 14:30 ET InventHelp Inventor Develops Modified Truck Body for Highway Construction Companies (TRO-1546)
construction company employees place/remove signs and pylons so I created an efficient and safer method to do so," said an inventor, from Westville, NS, Canada. My design increases safety, and it would reduce physical stress and strain for workers."
More news about: InventHelp
Feb 06, 2026, 08:33 ET Gallop Innotek Unveils Innovative GTP160-NS Silicone-Free Thermal Gap Pad
GALLOP INNOTEK today unveiled a new generation of silicone-free thermal gap pad, the GTP160-NS. This GTP160-NS is engineered to solve silicone outgassing or silicone bleeding in sensitive electronics, optical systems, satellite technology, and medical
More news about: Gallop Innotek
Feb 04, 2026, 13:44 ET Micross Launches Standard-Performance Nuclear Event Detector to Advance Radiation Protection for Critical Systems
solution with integrated differential line drivers and receiversResponse time reduced by more than 50% at 10X overdrive dose rate (3-5 ns with 20 to 50X overdrive)Unlike conventional NED designs developed more than 40 years ago, Micross' Standard-Performance NED integrates
More news about: Micross Components
Feb 04, 2026, 08:00 ET Liferaft to be acquired by Securitas
Acquisition positions Liferaft to expand intelligence-led security capabilities globallyHALIFAX, NS, Feb. 4, 2026 /PRNewswire/ -- Liferaft, a leading Open-Source Intelligence (OSINT) platform serving enterprise
More news about: Liferaft
Jan 29, 2026, 13:17 ET Piramal Pharma Limited annonce ses résultats pour le troisième trimestre et les neuf premiers mois de l'exercice 2026
NS(46)NS
More news about: Piramal Pharma Limited
Jan 28, 2026, 08:00 ET The 2026 NAMM Show Took Center Stage as Historic Gathering Celebrating the Future of Global Music Industry
https://www.namm.org/ns27onsitediscountMedia ContactsNAMM Communications - John Dolak, Director
More news about: NAMM (National Association of Music Merchants)
Jan 28, 2026, 07:00 ET Limy Raises $10M to Empower Brands to Activate the AI Storefront of the Future
Arcee.ai, Blitzy, Codecademy, FalconX, MongoDB, Noetica, NS1, and Splice.About a16z speedrun Speedrun is Andreessen Horowitz's (a16z) flagship program that invests in new startups across consumer/enterprise
More news about: Limy
Jan 21, 2026, 09:00 ET Norfolk Southern Launches East Edge Double-Stack Service Connecting Chicago and New England
historically constrained regions in our network. It reflects decades of persistence, problem–solving, and partnership — and I'm incredibly proud of our NS team and other partners who delivered it.""East Edge gives Norfolk Southern customers faster, more reliable service, and greater optionality across
More news about: Norfolk Southern Corporation
Jan 19, 2026, 09:00 ET Leviton Showcases Fiber Platforms for AI Data Centers and Extended Distance Copper Solutions for Enterprise Applications at BICSI Winter 2026
leviton.com/ns or
More news about: Leviton
Jan 15, 2026, 10:12 ET COVE SODA NAMES BRYAN CROWLEY CEO, POSITIONING BRAND FOR NEXT PHASE OF GROWTH IN FAST-EXPANDING FUNCTIONAL SODA CATEGORY
Beverage Industry Sales Veteran Craig Olikiewicz Named Chief Commercial OfficerHALIFAX, NS, Jan. 15, 2026 /PRNewswire/ -- As the functional soda category enters its next phase of growth, Cove Soda today
More news about: Cove Soda
Jan 15, 2026, 10:00 ET Leviton Announces Global Sales Leadership Transition
your network. Learn more at www.leviton.com/ns or linkedin.com/showcase/levitonns. European customers can visit leviton.com/ns/emea or linkedin.com/company/Leviton-ns-eu.About LevitonEvery day, Leviton builds what's next to light,
More news about: Leviton
Jan 13, 2026, 12:53 ET HCLTech Receita do terceiro trimestre do ano fiscal de 2026 subiu 4,2% em QoQ (CC), com receita anualizada ultrapassando US$ 15 bilhões; reservas excepcionalmente altas, com US$ 3 bilhões
13 de janeiro de 2026 /PRNewswire/ -- HCLTech (NSE: HCLTECH. NS) (BSE: HCLTECH.BO), empresa global líder em tecnologia, apresentou um desempenho forte no trimestre encerrado em 31 de dezembro de 2025, com receita em
More news about: HCLTech